Researcher profile
Daniela-Carmen Ababei
Affiliations
Organizations
Public evidence
7 connected articles
Acute Toxicity of Three Synthetic Cannabinoids: First In Vivo Preclinical Study.2026 · PubMed Central Open AccessTherapeutic relevance of an EU-GMP certified <i>Cannabis sativa</i> L. strain in a dual <i>in vivo</i> model of cognitive impairment and chronic neuropathic pain.2026 · Europe PMCEvaluation of long-term safety profile of an EU-GMP certified <i>Cannabis sativa</i> L. strain in a naturally aging preclinical model.2025 · Europe PMCExploring the impact of chronic intermittent EU-GMP certified Cannabis sativa L. therapy and its relevance in a rat model of aging.2025 · Europe PMCExploring Cannabinoids with Enhanced Binding Affinity for Targeting the Expanded Endocannabinoid System: A Promising Therapeutic Strategy for Alzheimer's Disease Treatment.2024 · Europe PMCAcute Toxicity and Pharmacokinetic Profile of an EU-GMP-Certified <i>Cannabis sativa</i> L. in Rodents.2023 · PubMed Central Open AccessMajor Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?2021 · Europe PMC
Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.